{"title":"Erlotinib: A Viewpoint by Natasha B. Leighl","authors":"N. Leighl","doi":"10.2165/00024669-200504040-00005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7698,"journal":{"name":"American Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00024669-200504040-00005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}